Literature DB >> 30741600

Impact of Pyridyl Moieties on the Inhibitory Properties of Prominent Acyclic Metal Chelators Against Metallo-β-Lactamase-Producing Enterobacteriaceae: Investigating the Molecular Basis of Acyclic Metal Chelators' Activity.

Sphelele C Sosibo1, Anou M Somboro2, Daniel G Amoako2, John Osei Sekyere3, Linda A Bester2, Jane C Ngila1, Darren D Sun1,4, Hezekiel M Kumalo5.   

Abstract

Carbapenem-resistant Enterobacteriaceae (CREs)-mediated infections remain a huge public health concern. CREs produce enzymes such as metallo-β-lactamases (MBLs), which inactivate β-lactam antibiotics. Hence, developing efficient molecules capable of inhibiting these enzymes remains a way forward to overcoming this phenomenon. In this study, we demonstrate that pyridyl moieties favor the inhibitory activity of cyclic metal-chelating agents through in vitro screening, molecular modeling, and docking assays. Di-(2-picolyl) amine and tris-(2-picolyl) amine exhibited great efficacy against different types of MBLs and strong binding affinity for NDM-1, whereas 2-picolyl amine did not show activity at a concentration of 64 mg/L in combination with meropenem; it further showed the lowest binding affinity from computational molecular analysis, commensurating with the in vitro screening assays. The findings revealed that the pyridyl group plays a vital role in the inhibitory activity of the tested molecules against CREs and should be exploited as potential MBL inhibitors.

Entities:  

Keywords:  Enterobacteriaceae; binding affinity; metal chelator; metallo-β-lactamase inhibitors; pyridyls

Mesh:

Substances:

Year:  2019        PMID: 30741600     DOI: 10.1089/mdr.2018.0272

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  1 in total

Review 1.  Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.

Authors:  Antonella R Palacios; María-Agustina Rossi; Graciela S Mahler; Alejandro J Vila
Journal:  Biomolecules       Date:  2020-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.